The United Kingdom
Rob Milnes has over 30 years of experience in financing and bringing ground-breaking medical technology and software to global markets, with the past 20 years focusing on women’s health. Co-inventor of 6 OvuSense patents and co-author of several clinical publications, he is also CEO of Fertility Focus Inc., the company’s wholly-owned US subsidiary. Rob has worked for Roche, Oxford Instruments, and was formerly a member of the Operations Board of Huntleigh Healthcare following the successful sale and integration of the Sonicaid Fetal Monitoring and Medilog Cardiology businesses. As well as product development and clinical experience, he has extensive experience in international sales & marketing, M&A, sub-contract manufacturing, finance and systems.